First Manhattan CO Genocea Biosciences, Inc. Transaction History

First Manhattan CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.01 - $1.38 $25 - $3,449	-2,500 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$2.06 - $2.82 $206 - $282	100 Added 4.17%	2,500 $5,000
Q1 2021 May 14, 2021	SELL	$2.35 - $4.01 $3,760 - $6,416	-1,600 Reduced 40.0%	2,400 $6,000
Q4 2020 Feb 16, 2021	BUY	$1.91 - $2.67 $7,640 - $10,680	4,000 New	4,000 $9,000

10K

Ticker GNCA
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,783,500
Description
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products incl...

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

Stay updated on First Manhattan CO with notifications on news.